Filing Details
- Accession Number:
- 0001104659-20-097220
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-20 16:05:36
- Reporting Period:
- 2020-08-18
- Accepted Time:
- 2020-08-20 16:05:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1533998 | Dariohealth Corp. | DRIO | Surgical & Medical Instruments & Apparatus (3841) | 452973162 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1817012 | Dennis Matheis | 8 Hatokhen St. Caesarea L3 3088900 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-08-18 | 15,000 | $0.00 | 65,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2020-08-18 | 20,000 | $0.00 | 20,000 | $18.68 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,000 | 2026-08-18 | No | 4 | A | Direct |
Footnotes
- The reporting person was awarded such securities in conjunction with his appointment as a board member of the registrant.
- The options will vest over a three years period commencing on August 18, 2020. One third of the options will become fully vested and exercisable on the first anniversary elapsed from the grant date, and the balance will vest in eight equal quarterly installments following the first anniversary of the grant date, subject to the director's continued service as a board member.